pepmg_

Study summary · research use only

Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy

Study · human · Neurodegenerative disease management · 2016 · DOI 10.2217/nmt-2016-0037 · PMID 27827552

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.